Alimera Sciences

Press Releases

All Releases
View Summary Alimera Sciences Signs Specialised Therapeutics Australia (STA) As Exclusive ILUVIEN® Distributor For Australia, New Zealand
Apr 28, 2014
PDF 12.8 KB Add to Briefcase
View Summary Alimera Sciences Secures $35 Million Debt Facility
Apr 25, 2014
PDF 12.0 KB Add to Briefcase
View Summary Alimera Sciences Announces New PDUFA Date For ILUVIEN®
Apr 14, 2014
PDF 11.6 KB Add to Briefcase
View Summary Alimera Sciences Announces Resubmission Of ILUVIEN® New Drug Application To FDA
Mar 27, 2014
PDF 11.3 KB Add to Briefcase
View Summary Alimera Sciences To Present At Cowen And Company 34th Annual Healthcare Conference
Feb 28, 2014
PDF 7.7 KB Add to Briefcase
View Summary Alimera Sciences Reports Fourth Quarter And Full Year 2013 Financial Results
Feb 27, 2014
PDF 34.5 KB Add to Briefcase
View Summary Alimera Sciences To Release Fourth Quarter And Fiscal Year 2013 Financial Results
Feb 20, 2014
PDF 8.1 KB Add to Briefcase
View Summary Alimera Sciences To Present At Citi 2014 Global Healthcare Conference
Feb 13, 2014
PDF 7.6 KB Add to Briefcase
View Summary Scottish Medicines Consortium Accepts ILUVIEN® For National Health Service Scotland
Feb 10, 2014
PDF 12.0 KB Add to Briefcase
View Summary Alimera Sciences Closes $37.5 Million Private Placement
Feb 3, 2014
PDF 10.0 KB Add to Briefcase
View Summary Alimera Sciences Announces $37.5 Million Private Placement
Jan 28, 2014
PDF 11.3 KB Add to Briefcase
View Summary Alimera Sciences Ships First ILUVIEN® Orders For U.K. National Health Service Hospitals
Jan 13, 2014
PDF 12.3 KB Add to Briefcase
View Summary Alimera Sciences and FDA Enter Into Labeling Discussions for ILUVIEN®, Agree Advisory Committee No Longer Necessary
Dec 18, 2013
PDF 13.2 KB Add to Briefcase
View Summary U.K.'s NICE Issues Final Guidance Recommending Alimera Sciences' ILUVIEN®
Dec 2, 2013
PDF 12.2 KB Add to Briefcase
View Summary Alimera Sciences Reports Third Quarter 2013 Financial Results
Nov 11, 2013
PDF 29.6 KB Add to Briefcase
View Summary Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming FDA Advisory Committee Meeting
Oct 31, 2013
PDF 9.3 KB Add to Briefcase
View Summary Alimera Sciences Receives Complete Response Letter For ILUVIEN®
Oct 18, 2013
PDF 13.3 KB Add to Briefcase
View Summary U.K.'s NICE Issues Final Appraisal Determination Recommending Alimera's ILUVIEN® for Chronic Diabetic Macular Edema
Sep 30, 2013
PDF 12.8 KB Add to Briefcase
View Summary Alimera Sciences Reports Second Quarter 2013 Financial Results
Aug 12, 2013
PDF 27.6 KB Add to Briefcase
View Summary Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results
Aug 5, 2013
PDF 8.1 KB Add to Briefcase
Showing 81-100 of 205 Page: 1 2 3 4 5 6 7 8 9 ... 11  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
/* */